Increase in cancer prevalence globally is the prominent factor projected to boost growth of the market of immune check activators during the forecast period Increase in government support and funding towards clinical trials on development of new drugs for cancer therapy also inspires the investigators in developing novel drugs. For instance, as of 2012 U.S. Department of Human Health and Services and National Cancer Institute raised funds of around US$ 5.1 billion to develop cancer drugs
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients